Frontlight ResearchEarly access
Trial site
Podlaskie Centrum Psychogeriatrii
- 7running trials
- 4closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease8 trials
- Depression3 trials
- Mild cognitive impairment3 trials
- Frontotemporal dementia1 trial
- Phase
- Phase 38 trials
- Phase 23 trials
- Status
- Active, not recruiting4 trials
- Completed4 trials
- Recruiting3 trials
- Lead sponsor
- Hoffmann-La Roche4 trials
- Eli Lilly and Company2 trials
- Neurocrine Biosciences2 trials
- AriBio Co., Ltd.1 trial
- F. Hoffmann-La Roche AG1 trial
- and 1 more
Running trials
Active, not recruiting
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Active, not recruiting
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Depression3 recruiting
Closed trials
Recruiting
Active, not recruiting
Completed
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Site data: ClinicalTrials.govUpdated 17 Nov 2026